Welcome to our dedicated page for PRESSURE BIOSCIENCES news (Ticker: PBIO), a resource for investors and traders seeking the latest updates and insights on PRESSURE BIOSCIENCES stock.
Pressure BioSciences, Inc. (PBIO) is a forefront life sciences company that focuses on the development and commercialization of an innovative platform technology known as Pressure Cycling Technology (PCT). This technology employs cycles of hydrostatic pressure, ranging from ambient to ultra-high levels (up to 35,000 psi and beyond), to precisely control biomolecular interactions, offering significant advancements in various scientific fields.
The company's core business revolves around leveraging PCT to enhance the analysis, study, and manipulation of biological samples. This technology has broad applications in areas such as protein characterization, pathogen inactivation, and the preparation of samples for genomic and proteomic studies. By utilizing PCT, researchers and scientists can achieve higher yields, improved quality, and better consistency in their biological analyses.
Recently, PBIO has made notable strides with the introduction of its new consumer products business unit, Uncle Bud’s. In January 2024, the company kicked off with a substantial $252,000 shipment of its Sunburn Soother to one of the world’s largest retailers, showcasing strong market demand and consumer interest. Additionally, VICAR Holdings LLC has committed to purchasing over 10,000 bottles of PBIO's best-in-class Nano-CBD topical spray in 2024, indicating a promising trajectory for their consumer products segment.
PBIO's relocation to a new facility has significantly increased their manufacturing space, enhanced operating efficiencies, and achieved measurable cost savings, setting the stage for unencumbered growth through multi-year expansion plans. The new facility is expected to support the company's long-term strategy and scale operations to meet growing demand.
Uncle Bud's acquisition has already yielded early synergies and measurable performance metrics within the first month, boosting PBIO's market presence and consumer engagement. This positive momentum highlights PBIO's capability to integrate and scale operations effectively.
Furthermore, Pressure BioSciences’ UltraShear platform continues to showcase its potential by enabling the development and launch of health and wellness products with groundbreaking bioavailability, fast onset, and effectiveness. This platform technology is a testament to PBIO's commitment to innovation and enhancing the quality and effectiveness of bio-molecular research and consumer applications.
Pressure BioSciences (PBIO) announced a partnership with Vita-Forte to create a highly bioavailable multi-antioxidant oral spray using PBIO's UltraShear Technology. The product will combine potent oil-based antioxidants like Acai, Curcumin, and CoQ10 into a fast-absorbing, nanoemulsified spray. Expected to be available by Fall 2024, this product aims to improve antioxidant absorption significantly. Vita-Forte, a leading distributor of superfood ingredients with annual revenues exceeding $20 million, will leverage its extensive customer base to facilitate market introduction and acceptance. This collaboration promises to deliver improved effectiveness and potency for nutraceutical products.
Pressure BioSciences (OTCQB: PBIO) will host a teleconference on June 20, 2024, at 4:30 PM ET to provide updates on various business and financial topics. Key points include the FY 2023 financial and business results, FY 2024 outlook, status of the company's relocation to a new manufacturing facility, and updates on a new Joint Venture Program. The company will also discuss product expansion plans, including new nanoemulsified products expected to release in Q3/Q4 2024, and the placement of first-generation UltraShear benchtop equipment in multiple cannabis companies for THC edible products. Stakeholders can listen live or via replay on the company's website.
Pressure BioSciences (OTCQB: PBIO) announced a teleconference to update stakeholders on June 19, 2024, at 4:30 PM ET. Key topics include FY 2023 financial and business results, the FY 2024 outlook, the status of the company's new manufacturing facility, and updates on Uncle Bud’s Health and Wellness product expansion. New nanoemulsified products are expected to launch commercially in Q3/Q4 2024, including next-generation skincare with nano-retinol, a nootropic enhancer, and a best-in-class antioxidant cocktail. Additionally, the placement of the 1st Generation UltraShear benchtop equipment into cannabis companies will be discussed. The teleconference will include a presentation and a Q&A session. Interested parties can participate live or access a replay via the company's website.
FAQ
What is the current stock price of PRESSURE BIOSCIENCES (PBIO)?
What is the market cap of PRESSURE BIOSCIENCES (PBIO)?
What is Pressure BioSciences, Inc. (PBIO)?
What is Pressure Cycling Technology (PCT)?
In which areas is PCT technology applied?
What recent achievements has PBIO made?
What is Uncle Bud’s?
How has PBIO's new facility impacted the company?
What is the UltraShear platform?
How has Uncle Bud’s performed since its acquisition?
What are some applications of PBIO’s products?
What is the significance of PBIO’s consumer products?
